Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FDG‐PET Patterns Predict Amyloid Deposition and Clinical Profile in Corticobasal Syndrome
Jacy Bezerra Parmera, Artur Martins Coutinho, Mateus Rozalem Aranha, et al.
Movement Disorders (2020) Vol. 36, Iss. 3, pp. 651-661
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

18F‐Florzolotau Positron Emission Tomography Imaging of Tau Pathology in the Living Brains of Patients with Corticobasal Syndrome
Fengtao Liu, Jiaying Lu, Xinyi Li, et al.
Movement Disorders (2023) Vol. 38, Iss. 4, pp. 579-588
Closed Access | Times Cited: 15
Pathomechanisms of neuropsychiatric disturbances in atypical parkinsonian disorders: a current view
K. A. Jellinger
Journal of Neural Transmission (2025)
Closed Access
Relationships between hypometabolism and both β‐amyloid and tau PET in corticobasal syndrome
Alma Ghirelli, Austin W. Goodrich, Yehkyoung C. Stephens, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access
Additive value of [18F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome
Sabrina Katzdobler, Alexander Nitschmann, Henryk Barthel, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 50, Iss. 2, pp. 423-434
Open Access | Times Cited: 21
Early‐phase amyloid PET reproduces metabolic signatures of cognitive decline in Parkinson's disease
William Aye, Megan Stark, Kyla‐Louise Horne, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2024) Vol. 16, Iss. 2
Open Access | Times Cited: 4
Biomarkers of neurodegeneration across the Global South
Eimear McGlinchey, Claudia Durán-Aniotz, Rufus Akinyemi, et al.
The Lancet Healthy Longevity (2024), pp. 100616-100616
Open Access | Times Cited: 4
Blood based biomarkers for movement disorders
Huw R. Morris
Acta Neurologica Scandinavica (2022) Vol. 146, Iss. 4, pp. 353-361
Open Access | Times Cited: 16
Dual-Phase β-Amyloid PET Captures Neuronal Injury and Amyloidosis in Corticobasal Syndrome
Julia Schmitt, Carla Palleis, Julia Sauerbeck, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 18
Pathomechanisms of cognitive and behavioral impairment in corticobasal degeneration
K. A. Jellinger
Journal of Neural Transmission (2023) Vol. 130, Iss. 12, pp. 1509-1522
Closed Access | Times Cited: 7
Conventional magnetic resonance imaging key features for distinguishing pathologically confirmed corticobasal degeneration from its mimics: a retrospective analysis of the J-VAC study
Keita Sakurai, Aya M. Tokumaru, Mari Yoshida, et al.
Neuroradiology (2024) Vol. 66, Iss. 11, pp. 1917-1929
Open Access | Times Cited: 2
Guidelines for the use and interpretation of Alzheimer’s disease biomarkers in clinical practice in Brazil: recommendations from the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology
Adalberto Studart Neto, Breno José Alencar Pires Barbosa, Artur Martins Coutinho, et al.
Dementia & Neuropsychologia (2024) Vol. 18
Open Access | Times Cited: 2
Nuclear imaging in Parkinson's disease: The past, the present, and the future
Haim Golan, Olga Volkov, Eli Shalom
Journal of the Neurological Sciences (2022) Vol. 436, pp. 120220-120220
Closed Access | Times Cited: 11
Progressive supranuclear palsy and corticobasal degeneration: novel clinical concepts and advances in biomarkers
Jacy Bezerra Parmera, Marcos Castello Barbosa de Oliveira, Roberta Diehl Rodrigues, et al.
Arquivos de Neuro-Psiquiatria (2022) Vol. 80, Iss. 5 suppl 1, pp. 126-136
Open Access | Times Cited: 11
Imaging the Functional Neuroanatomy of Parkinson’s Disease: Clinical Applications and Future Directions
Fulvio Lauretani, Yari Longobucco, Giulia Ravazzoni, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 5, pp. 2356-2356
Open Access | Times Cited: 15
Metabolic and Structural Signatures of Speech and Language Impairment in Corticobasal Syndrome: A Multimodal PET/MRI Study
Jacy Bezerra Parmera, Isabel Junqueira de Almeida, Marcos Castello Barbosa de Oliveira, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 12
Dopaminergic Correlates of Regional Cerebral Blood Flow in Parkinsonian Disorders
Yoshikazu Nakano, Shigeki Hirano, Kazuho Kojima, et al.
Movement Disorders (2022) Vol. 37, Iss. 6, pp. 1235-1244
Closed Access | Times Cited: 8
The enigma of depression in corticobasal degeneration, a frequent but poorly understood co-morbidity
K. A. Jellinger
Journal of Neural Transmission (2024) Vol. 131, Iss. 3, pp. 195-202
Closed Access | Times Cited: 1
Differential Synaptic Loss in β‐Amyloid Positive Versus β‐Amyloid Negative Corticobasal Syndrome
Negin Holland, George Savulich, P. Simon Jones, et al.
Movement Disorders (2024) Vol. 39, Iss. 7, pp. 1166-1178
Open Access | Times Cited: 1
The possible connection between neutrophil-to-high-density lipoprotein ratio and cerebral perfusion in clinically established corticobasal syndrome: a pilot study
Patryk Chunowski, Bartosz Migda, Natalia Madetko, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 1
FDG-PET patterns associated with ideomotor apraxia and imitation apraxia in patients with corticobasal syndrome
Sungyang Jo, Jungsu S. Oh, E‐Nae Cheong, et al.
Parkinsonism & Related Disorders (2021) Vol. 88, pp. 96-101
Closed Access | Times Cited: 7
The Role of Dual-Phase 18F-FP-CIT PET to Early Diagnosis of Corticobasal Syndrome
Min Seung Kim, Dong Gueu Park, In Ja Shin, et al.
Clinical Nuclear Medicine (2023) Vol. 49, Iss. 2, pp. 124-130
Closed Access | Times Cited: 2
Probable 4‐Repeat Tauopathy Criteria Predict Brain Amyloid Negativity, Distinct Clinical Features, and FDG‐PET/MRI Neurodegeneneration Patterns in Corticobasal Syndrome
Jacy Bezerra Parmera, Camila de Godoi Carneiro, Isabel Junqueira de Almeida, et al.
Movement Disorders Clinical Practice (2023) Vol. 11, Iss. 3, pp. 238-247
Closed Access | Times Cited: 2
The Discourse Profile in Corticobasal Syndrome: A Comprehensive Clinical and Biomarker Approach
Isabel Junqueira de Almeida, Marcela Lima Silagi, Maria Teresa Carthery‐Goulart, et al.
Brain Sciences (2022) Vol. 12, Iss. 12, pp. 1705-1705
Open Access | Times Cited: 4
Phenotypic and Positron Emission Tomography with [18F]fluordeoxyglucose (FDG PET) differences in corticobasal syndrome: comparison of two cases
Thais Winkeler Beltrão, Eduardo Barbosa de Albuquerque Maranhão, Victor Adill Gomes Correia, et al.
Dementia & Neuropsychologia (2024) Vol. 18
Open Access
An Understanding of Different Mechanisms Leading to Neurodegenerative Diseases
Diana G. Sami, Mohamed Salama
(2024), pp. 173-224
Closed Access
Page 1 - Next Page

Scroll to top